Goldman Sachs Knock-Out PGR/ DE000GG7EGK8 /
| 2024-05-10 9:36:51 PM | Chg.- | Bid10:07:46 AM | Ask10:07:46 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.760EUR | - | 0.620 Bid Size: 5,000 |
0.820 Ask Size: 1,000 |
Progressive Corporat... | 222.4776 USD | 2078-12-31 | Put |
GlobeNewswire
8:30 AM
Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase...
GlobeNewswire
05-09
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
05-09
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
05-08
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire
05-07
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...
GlobeNewswire
05-06
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire
05-04
The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire
05-02
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
GlobeNewswire
05-01
Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...
GlobeNewswire
05-01
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
04-25
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire
04-24
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
GlobeNewswire
04-22
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire
04-22
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire
04-19
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...
GlobeNewswire
04-18
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...
